This interview features J.D. Mowery, president and chief executive officer, KBI Biopharma, who discusses the company's SUREtechnology platform that technology enables KBI to streamline production from clone selection all the way through GMP manufacturing.

Register or Login and hit Watch on Demand to view the recorded interview now.